Trelia J. Craft

566 total citations
16 papers, 323 citations indexed

About

Trelia J. Craft is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Trelia J. Craft has authored 16 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Trelia J. Craft's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Protease and Inhibitor Mechanisms (4 papers). Trelia J. Craft is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers) and Protease and Inhibitor Mechanisms (4 papers). Trelia J. Craft collaborates with scholars based in United States and United Kingdom. Trelia J. Craft's co-authors include Gerald F. Smith, Brian J. Eastwood, Mark W. Farmen, Jeffrey K. Smallwood, Philip W. Iversen, Neil W. DeLapp, Leonard C. Weir, Michael R. Wiley, Donetta S. Gifford‐Moore and Noel D. Jones and has published in prestigious journals such as Circulation, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Trelia J. Craft

16 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trelia J. Craft United States 9 119 109 53 48 45 16 323
Francis P. Barbone United States 14 323 2.7× 168 1.5× 30 0.6× 134 2.8× 27 0.6× 16 629
Pamela Roper United States 7 145 1.2× 55 0.5× 21 0.4× 100 2.1× 47 1.0× 11 349
J. Hauptmann Germany 13 130 1.1× 182 1.7× 46 0.9× 81 1.7× 37 0.8× 43 549
Albert Liclican United States 10 254 2.1× 54 0.5× 136 2.6× 77 1.6× 43 1.0× 14 483
Dao Lentz United States 8 207 1.7× 45 0.4× 81 1.5× 39 0.8× 51 1.1× 10 340
Joseph E. Myers United States 10 283 2.4× 56 0.5× 89 1.7× 59 1.2× 28 0.6× 12 488
Jörg Hauptmann Germany 11 153 1.3× 196 1.8× 93 1.8× 87 1.8× 44 1.0× 13 423
Girija Krishnamurthy United States 14 205 1.7× 45 0.4× 186 3.5× 40 0.8× 88 2.0× 17 661
Mary K. Wolpert-DeFilippes United States 10 268 2.3× 40 0.4× 126 2.4× 215 4.5× 60 1.3× 13 507
James Zweibel United States 8 258 2.2× 38 0.3× 26 0.5× 123 2.6× 70 1.6× 10 370

Countries citing papers authored by Trelia J. Craft

Since Specialization
Citations

This map shows the geographic impact of Trelia J. Craft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trelia J. Craft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trelia J. Craft more than expected).

Fields of papers citing papers by Trelia J. Craft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trelia J. Craft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trelia J. Craft. The network helps show where Trelia J. Craft may publish in the future.

Co-authorship network of co-authors of Trelia J. Craft

This figure shows the co-authorship network connecting the top 25 collaborators of Trelia J. Craft. A scholar is included among the top collaborators of Trelia J. Craft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trelia J. Craft. Trelia J. Craft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Masters, John J., Valentine J. Klimkowski, Michael Chouinard, et al.. (2007). Investigation of the terminal P4 domain in a series of d-phenylglycinamide-based factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(24). 6910–6913. 1 indexed citations
2.
Klimkowski, Valentine J., Brian M. Watson, Michael R. Wiley, et al.. (2007). d-Phenylglycinol-derived non-covalent factor Xa inhibitors: Effect of non-peptidic S4 linkage elements on affinity and anticoagulant activity. Bioorganic & Medicinal Chemistry Letters. 17(21). 5801–5805. 6 indexed citations
3.
Eastwood, Brian J., Mark W. Farmen, Philip W. Iversen, et al.. (2006). The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies. SLAS DISCOVERY. 11(3). 253–261. 100 indexed citations
4.
Masters, John J., Jennifer M. Tinsley, Trelia J. Craft, et al.. (2005). Investigation of factor Xa inhibitors containing non-amidine S1 elements. Bioorganic & Medicinal Chemistry Letters. 15(21). 4838–4841. 6 indexed citations
5.
Yee, Ying K., Douglas W. Beight, Trelia J. Craft, et al.. (2000). N2-Aroylanthranilamide Inhibitors of Human Factor Xa. Journal of Medicinal Chemistry. 43(5). 873–882. 35 indexed citations
6.
Smith, Gerald F., Robert T. Shuman, Trelia J. Craft, et al.. (1996). A Family of Arginal Thrombin Inhibitors Related to Efegatran. Seminars in Thrombosis and Hemostasis. 22(2). 173–183. 16 indexed citations
7.
Wiley, Michael R., Nickolay Y. Chirgadze, David K. Clawson, et al.. (1996). D-Phe-Pro-p-Amidinobenzylamine: A potent and highly selective thrombin inhibitor. Bioorganic & Medicinal Chemistry Letters. 6(20). 2387–2392. 33 indexed citations
8.
Wiley, Michael R., Nickolay Y. Chirgadze, David K. Clawson, et al.. (1995). Serine protease selectivity of the thrombin inhibitor D-Phe-Pro-Agmatine and its homologs. Bioorganic & Medicinal Chemistry Letters. 5(23). 2835–2840. 28 indexed citations
9.
Schacht, Aaron L., Michael R. Wiley, Nickolay Y. Chirgadze, et al.. (1995). N-substituted glycines as replacements for proline in tripeptide aldehyde thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 5(21). 2529–2534. 6 indexed citations
10.
Smith, Gerald F., et al.. (1993). Pharmacodynamics of modified tissue plasminogen activator LY210825 in the conscious dog as evaluated with immunocapture assays. Fibrinolysis and Proteolysis. 7(4). 264–274. 1 indexed citations
11.
Jackson, Charles V., et al.. (1992). Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.. Journal of Pharmacology and Experimental Therapeutics. 260(1). 64–70. 6 indexed citations
12.
Sall, Daniel J., et al.. (1992). Characterization of LY806303 as a potent and selective inhibitor of thrombin. Bioorganic & Medicinal Chemistry Letters. 2(9). 1025–1028. 1 indexed citations
13.
Jackson, Charles V., Trelia J. Craft, Brian W. Grinnell, et al.. (1990). Thrombolytic activity of a novel plasminogen activator, LY210825, compared with recombinant tissue-type plasminogen activator in a canine model of coronary artery thrombosis.. Circulation. 82(3). 930–940. 23 indexed citations
14.
Craft, Trelia J., et al.. (1985). Topographics of dry skin, non-dry skin, and cosmetically treated dry skin as quantified by skin profilometry. Journal of the Society of Cosmetic Chemists. 36(2). 143–152. 15 indexed citations
15.
Craft, Trelia J., et al.. (1982). Quantification of the skin's topography by skin profilometry. International Journal of Cosmetic Science. 4(5). 195–205. 27 indexed citations
16.
Smith, Gerald F. & Trelia J. Craft. (1976). Heparin reacts stoichiometrically with thrombin during thrombin inhibition in human plasma. Biochemical and Biophysical Research Communications. 71(3). 738–745. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis P. Barbone Breakdown of academic impact, for papers by Pamela Roper Breakdown of academic impact, for papers by J. Hauptmann Breakdown of academic impact, for papers by Albert Liclican Breakdown of academic impact, for papers by Dao Lentz Breakdown of academic impact, for papers by Joseph E. Myers Breakdown of academic impact, for papers by Jörg Hauptmann Breakdown of academic impact, for papers by Girija Krishnamurthy Breakdown of academic impact, for papers by Mary K. Wolpert-DeFilippes Breakdown of academic impact, for papers by James Zweibel
Rankless by CCL
2026